Anemia and transfusion of red blood cells
Article Sidebar
Main Article Content
The red cells transfusion is a mainstay in the treatment of anemic patients. These blood transfusions are not without risks.The risk-benefit profile for red cell transfusions to treat anaemia is uncertain, but they may contribute to adverse patient outcomes in some situations. The ability of a patient to tolerate anaemia depends on their clinical condition and the presence of any significant co-morbidity; maintenance of circulating volume is of paramount importance. There is no universal transfusion trigger. Advances in the development and validation of physiological, accessible, practical and reliable markers to guide therapy are expected. To improve patients’ outcomes, further study is required to more fully explore the risk of anemia, optimal hemoglobin level, and the risk and efficacy of RBC transfusion. Future clinical investigations with high priority should determine the efficacy of transfusion in those classified as uncertain scenarios. In the absence of data, it is prudent that transfusion is administered with caution in these clinical scenarios.
- Anaemia
- blood transfusion
- transfusion practice
AABB. The 2007 national blood collection and utilization survey report. http://www.aabb.org/ programs/biovigilance/nbcus/Documents/07nbcusrpt.pdf. Accessed 15 April 2011.
Perioperative Red Cell Transfusion. NIH Consens Dev Conf Consens Statement. 1988; 7(4): 1-19.
Weiskopf RB. Do we know when to transfuse red cells to treat acute anemia?. Transfusion 1998; 38: 517-21. DOI: https://doi.org/10.1046/j.1537-2995.1998.38698326330.x
Marik PE, Corwin HL. Eficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crít Care Med. 2008; 36: 2667–74.
Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999; 340: 409-17. DOI: https://doi.org/10.1056/NEJM199902113400601
Hebert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crít Care Med. 2001; 29: 227-34. DOI: https://doi.org/10.1097/00003246-200102000-00001
Lacroix J, Hebert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007; 356: 1609-19. DOI: https://doi.org/10.1056/NEJMoa066240
Carson JL, Terrin ML, Magaziner J, Chaitman BR, Apple FS, Heck DA, et al. LBA-6 Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS): The principle results. Paper presented at the 51st Annua l Meeting of the American Society of Hematology, December 5-9, 2009.
Napolitano LM, Corwin HL. Efficacy of red blood cell transfusion in the critically ill. Crít Care Clin. 2004; 20: 255-68. DOI: https://doi.org/10.1016/j.ccc.2003.12.002
Madjdpour C, Spahn DR. Allogeneic red blood cell transfusion: Physiology of oxygen transport. Best Pract Res Clin Anaesthesiol. 2007; 21: 163-71. DOI: https://doi.org/10.1016/j.bpa.2007.01.001
Vincent JL, Sakr Y, De Backer D, Van der Linden P. Efficacy of allogeneic red blood cell transfusions. Best Pract Res Clin Anaesthesiol. 2007; 21: 209-19. DOI: https://doi.org/10.1016/j.bpa.2007.01.005
Fernandes CJ Jr, Akamine N, De Marco FV, De Souza JA, Lagudis S, Knobel E. Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crít Care. 2001; 5: 362-7. DOI: https://doi.org/10.1186/cc1070
Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, et al. The CRIT study: anemia and blood transfusion in the critically ill—current clinical practice in the United States. Crít Care Med. 2004; 32: 39-52. DOI: https://doi.org/10.1097/01.CCM.0000104112.34142.79
Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A. et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002; 288: 1499-1507. DOI: https://doi.org/10.1001/jama.288.12.1499
Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma. 2003; 54: 908-14. DOI: https://doi.org/10.1097/01.TA.0000022460.21283.53
Palmieri TL, Caruso DM, Foster KN, Cairns BA, Peck MD, Gamelli RL. et al. Effect of blood transfusion on outcome after major burn injury: A multicenter study. Crít Care Med. 2006; 34: 1602-7. DOI: https://doi.org/10.1097/01.CCM.0000217472.97524.0E
Stone TJ, Riesenman PJ, Charles AG. Red blood cell transfusion within the first 24 hours of admission is associated with increased mortality in the pediatric trauma population: A retrospective cohort study. J Trauma Manag Outcomes. 2008; 2: 9-13. DOI: https://doi.org/10.1186/1752-2897-2-9
Marik PE, Corwin HL. Eficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crít Care Med. 2008; 36: 2667–74. DOI: https://doi.org/10.1097/CCM.0b013e3181844677
Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009; 113: 3406-17. DOI: https://doi.org/10.1182/blood-2008-10-167643
Lieberman JA, Weiskopf RB, Kelley SD, Feiner J, Noorani M, Leung J, Toy P. et al. Critical oxygen delivery in conscious humans is less than 7.3 ml O2. kg-1. min-1. Anesthesiology. 2000; 92:407-13. DOI: https://doi.org/10.1097/00000542-200002000-00022
Ronco JJ, Fenwick JC, Tweeddale MG, Wiggs BR, Phang PT, Cooper DJ. et al. Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA. 1993; 270: 1724-30. DOI: https://doi.org/10.1001/jama.270.14.1724
Klein H, Spahn D, Carson J. Red blood cell transfusion in clinical practice. Lancet. 2007; 370: 415-26. DOI: https://doi.org/10.1016/S0140-6736(07)61197-0
Madjdpour C, Spahn D. Allogeneic red blood cell transfusions: Efficacy, risks, alternatives and indications. Br J Anesthesiol. 2005; 95: 33-42. DOI: https://doi.org/10.1093/bja/aeh290
Madjdpour C, Spahn D, Weiskopf R. Anemia and perioperative red blood cell transfusion: A matter of tolerance. Crít Care Med. 2006; 34: S102-S8. DOI: https://doi.org/10.1097/01.CCM.0000214317.26717.73
Gerber D. Transfusion of packed red blood cells in patients with ischemic heart disease. Crít Care Med. 2008; 36: 1068-74. DOI: https://doi.org/10.1097/CCM.0b013e318169251f
Nohara R. Diagnosis with O2 kinetics. Old but new. Circulation J. 2009; 73: 1795-6. DOI: https://doi.org/10.1253/circj.CJ-09-0585
Van Woerkens EC, Trouwborst A, van Lanschot JJ: Profound hemodilution: what is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human?. Anesth Analg. 1992; 75: 818-21. DOI: https://doi.org/10.1213/00000539-199211000-00029
Weiskopf RB, Feiner J, Hopf HW, Viele MK, Watson JJ, Kramer JH. et al. Oxygen reverses deficits of cognitive function and memory and increased heart rate induced by acute severe isovolemic anemia. Anesthesiology. 2002; 96: 871–7. DOI: https://doi.org/10.1097/00000542-200204000-00014
Weiskopf RB, Feiner J, Hopf H, Lieberman J, Finlay HE, Quah C. et al. Fresh blood and aged stored blood are equally eficacious in immediately reversing anemia induced brain oxygenation deficits in humans. Anesthesiology. 2006; 104: 911–20. DOI: https://doi.org/10.1097/00000542-200605000-00005
Weiskopf RB, Viele MK, Feiner J, Kelley S, Lieberman J, Noorani M. et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA. 1998; 279: 217–21. DOI: https://doi.org/10.1001/jama.279.3.217
Spahn DR, Smith LR, Veronee CD, McRae RL, Hu WC, Menius AJ, et al. Acute isovolemic hemodilution and blood transfusion. Effects on regional function and metabolism in myocardium with compromised coronary blood flow. JThorac Cardiovasc Surg. 1993; 105: 694–704. DOI: https://doi.org/10.1016/S0022-5223(19)34196-0
Levy PS, Kim SJ, Eckel PK, Chavez R, Ismail EF, Gould SA, et al. Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis. Am J Physiol. 1993; 265: H340–9. DOI: https://doi.org/10.1152/ajpheart.1993.265.1.H340
Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP, Saha SP, Hessel EA 2nd, Haan CK, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline. Ann Thorac Surg. 2007; 83: s27-86. DOI: https://doi.org/10.1016/j.athoracsur.2007.02.099
Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care. Crít Care Med. 2009; 37(12): 3124-57. DOI: https://doi.org/10.1097/CCM.0b013e3181b39f1b
Wang J, Klein H. Red blood cell transfusion in the treatment and management of anaemia: The search for the elusive transfusion trigger. Vox Sang. 2010; 98: 2-11. DOI: https://doi.org/10.1111/j.1423-0410.2009.01223.x
Vamvakas EC: Evidence-based practice of transfusion medicine: Is it possible and what do the words mean? Transfus Med Rev. 2004; 18: 267-8. DOI: https://doi.org/10.1016/j.tmrv.2004.06.003
Sehat KR, Evans R, Newman JH. How much blood is really lost in total knee arthroplasty?. Correct blood loss management should take hidden loss into account. Knee. 2000; 7:151-5. DOI: https://doi.org/10.1016/S0968-0160(00)00047-8
Cavaliere F, Martinelli L, Guarnieri S, Varano C, Rossi M, Schiavello R. Arterial-venous PCO2 gradient in early postoperative hours following myocardial revascularization. J Cardiovasc Surg. 1996; 37: 499-503.
Carson JI, Chen AY. In search of the transfusion trigger. Clin Orthop. 1998; 357: 30-5. DOI: https://doi.org/10.1097/00003086-199812000-00005
Lundsgard-Hansen P. Safe hemoglobin or hematocrit levels in surgical patients. Worl J Surg. 1996; 20: 1182-8. DOI: https://doi.org/10.1007/s002689900180
Deans K, Minneci PC, Suffredini AF, Danner RL, Hoffman WD, Ciu X, et al. Randomization in clinical trials of titrated therapies: Unintended consequences of using fixed treatment protocols. Crit Care Med. 2007; 35: 1509-16. DOI: https://doi.org/10.1097/01.CCM.0000266584.40715.A6
Grover M, Talwalkar S, Casbard A, Boralessa H, Contreras M, Boralessa H, et al. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang. 2006; 90: 105-12. DOI: https://doi.org/10.1111/j.1423-0410.2006.00730.x
Murphy GJ, Rizvi S, Battaglia F, Culliford L, Rogres C, Cohen A, et al. A pilot randomised controlled trial of the effect of transfusion threshold reduction on transfusion rates and morbidity after cardiac surgery. Society for Cardiothoracic Surgery in Great Britain and Ireland. Annual meeting 2007; 94. http://www.scts.org/documents/PDF/FinalPrinted Programme24Feb2007.pdf.
Slight RD, O´Donohoe P, Fung AKY, Alonzi C, McClelland DBL, Mankad PS. Rationalizing blood transfusion in cardiac surgery: the impact of a red cell volume-based guideline on blood usage and clinical outcome. Vox Sang. 2008; 95: 205-10. DOI: https://doi.org/10.1111/j.1423-0410.2008.01083.x
Haijar LA, Vincent JL, Galas FRBG, Nakamura RE, Silva CMP, Santos MH, et al. Transfusion requirements after cardiac surgery. The TRACS randomized controlled trial. JAMA. 2010; 304: 1559-67. DOI: https://doi.org/10.1001/jama.2010.1446
Willems A, Harrington K, Lacroix J, Biarent D, Joffe AR, Wensley D, et al. Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: a a subgroup analysis. Crit Care Med. 2010; 38: 649-56. DOI: https://doi.org/10.1097/CCM.0b013e3181bc816c
Rouette J, Trottier H, Ducruet T, Beaunoyer M, Lacroix J, Tucci M. et al. Red blood cell transfusion threshold in postsurgical pediatric intensive care patients. A randomized clinical trial. Ann Surg. 2010; 251: 421-7. DOI: https://doi.org/10.1097/SLA.0b013e3181c5dc2e
Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011; 365: 2453-62. DOI: https://doi.org/10.1056/NEJMoa1012452
Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M, Kehlet H. The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion. 2009; 49: 227-34. DOI: https://doi.org/10.1111/j.1537-2995.2008.01967.x
Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012; 157(1):49-58. DOI: https://doi.org/10.7326/0003-4819-157-1-201206190-00429
Kosecoff J, Kanouse DE, Rogers WH, McCloskey L, Winslow CM, Brook RH. Effects of the national institutes of health consensus development program on physician practice. JAMA. 1987; 258: 2708–13. DOI: https://doi.org/10.1001/jama.258.19.2708
Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med. 1989; 321: 1306–11. DOI: https://doi.org/10.1056/NEJM198911093211906
Hill MN, Levine DM, Whelton PK. Awareness, use, and impact of the 1984 Joint National Committee consensus report on high blood pressure. Am J Public Health. 1988; 78: 1190–4. DOI: https://doi.org/10.2105/AJPH.78.9.1190
Eisenstaedt RS. Modifying physicians’ transfusion practice. Transfus Med Rev. 1997; 11: 27–37. DOI: https://doi.org/10.1016/S0887-7963(97)80007-7
Salem-Schatz S, Avorn J, Soumerai SB. Influence of clinical knowledge, organizational context, and practice style on transfusion decision making. Implications for practice change strategies. JAMA. 1990; 264: 476–83. DOI: https://doi.org/10.1001/jama.264.4.476
Brown RL, Brown RL, Edwards JA, Nutz JF. Variation in a medical faculty’s decisions to transfuse. Implications for modifying blood product utilization. Med Care. 1992; 30(12):1083-96. DOI: https://doi.org/10.1097/00005650-199212000-00002
Downloads
- Luis Eduardo Bravo, Armando Cortés, Edwin Carrascal, Roberto Jaramillo, Luz Stella García, Paco Eduardo Bravo, Aníbal Badel, Pablo Andrés Bravo, Helicobacter pylori: patología y prevalencia en biopsias gástricas en Colombia. , Colombia Medica: Vol. 34 No. 3 (2003)
- Armando Cortés, Wilson Wedekin, Fabiola Bolaños, Reanimación con glóbulos rojos Rh positivo y sin prueba cruzada en emergencias médicas. , Colombia Medica: Vol. 35 No. 4 (2004)
- Armando Cortés, Edgar Flor, Germán Duque, Análisis de costos de la atención médica hospitalaria Experiencia en una clínica privada de nivel II-III. , Colombia Medica: Vol. 33 No. 2 (2002)
- Luis Eduardo Bravo, Luz Stella García, Paola Collazos, Edwin Carrascal, Oscar Ramírez, Armando Cortés, Marcela Nuñez, Erquinovaldo Millán, Reliable information for cancer control in Cali, Colombia , Colombia Medica: Vol. 49 No. 1 (2018): Colombia Cancer Epidemiology
- Armando Cortés, Jaime E. Olaya, Giovanna Figueredo, Transfusión ambulatoria y domiciliaria: una alternativa de terapia extrahospitalaria. Experiencia de 9 años en un banco de sangre regional en Cali . , Colombia Medica: Vol. 33 No. 1 (2002)
- Armando Cortés, Lina María Isaza, Luis Eduardo Bravo, María Fernanda Palomino, Incidencia de seroconversión para infecciones virales trasmisibles por transfusión en donantes habituales de sangre en Cali. , Colombia Medica: Vol. 32 No. 4 (2001)
- Marta Gallego, Lorena Muñoz, Armando Cortés, Características socioculturales de los donantes y no donantes de sangre en Colombia. , Colombia Medica: Vol. 31 No. 3 (2000)
- Edwin Carrascal, Armando Cortés, Suminori Akiba, Oscar Tamayo, Francisco Quiñónez, Luisa Flórez, Blanca Piazuelo, Epidemiología y patología de la leucemia/linfoma de células T del adulto en Cali y el suroccidente colombiano. , Colombia Medica: Vol. 35 No. 1 (2004)
- Armando Cortés, Marcela García Gutiérrez, Prevalencia de marcadores para infecciones transmisibles por transfusión en donantes voluntarios. , Colombia Medica: Vol. 27 No. 1 (1996)
- Luis Eduardo Bravo, Armando Cortés, Edwin Carrascal, Pelayo Correa, Nora Ordóñez, Seroprevalencia de anticuerpos anti-Helicobacter pylori en donantes de sangre de regiones colombianas con diferencias en la mortalidad por cáncer gástrico. , Colombia Medica: Vol. 31 No. 3 (2000)
Similar Articles
- Armando Cortés, Martha Lucía Jiménez, Ariadna Fajardo, Gloria Valencia, Martha Cecilia Marín, Norma Sandoval, Deficiencia de hierro en donantes de sangre. , Colombia Medica: Vol. 36 No. 1 (2005)
- Diana Palencia, Carlos Julio Mendoza, Javier Torres, Carlos Armando Echandía, Kangaroo mother program: physical growth and morbidity in a cohort of children, followed from 40 weeks of postconceptional age until first year. , Colombia Medica: Vol. 40 No. 3 (2009)
You may also start an advanced similarity search for this article.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use